IXICO Interim Results to 31st March 2014

June 6, 2014
News Download PDF

IXICO publishes its unaudited interim results for the six months ended on March 31st, 2014. Announcements include the successful launch of ASSESSA® and significant progress in clinical trials and experimental medicine business.

The highlights are as follows:

  • Successful launch of ASSESSA®, the CE-marked digital healthcare platform for decision-support in dementia diagnosis
  • Expansion in clinical trials and experimental medicine business
  • Continuing business development in China
  • Financial performance on budget and in line with expectations

Other recent developments:

  • Contract award by the Small Business Research Initiative for Healthcare for the development of a digital health application designed to support dementia sufferers post-diagnosis - view
  • Two separate clinical trials awarded with top fifteen pharma companies in HD - view

To view to full announcement and for a statement from Prof. Derek Hill, CEO IXICO, please download the attached press release.